|
1 Indications And Usage Zontivity Is A Protease-Activated Receptor-1 (Par-1) Antagonist Indicated For The Reduction Of Thrombotic Cardiovascular Events In Patients With A History Of Myocardial Infarction (Mi) Or With Peripheral Arterial Disease (Pad). Zontivity Has Been Shown To Reduce The Rate Of A Combined Endpoint Of Cardiovascular Death, Mi, Stroke, And Urgent Coronary Revascularization. ( 1.1 ) 1.1 Patients With History Of Myocardial Infarction (Mi) Or With Peripheral Arterial Disease (Pad) Zontivity ® Is Indicated For The Reduction Of Thrombotic Cardiovascular Events In Patients With A History Of Myocardial Infarction (Mi) Or With Peripheral Arterial Disease (Pad). Zontivity Has Been Shown To Reduce The Rate Of A Combined Endpoint Of Cardiovascular Death, Mi, Stroke, And Urgent Coronary Revascularization (Ucr).
|